CCMH
CHRS icon

Cornerstone Capital Management Holdings’s Coherus Oncology CHRS Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$314K Buy
35,762
+9,100
+34% +$97.4K ﹤0.01% 1072
2017
Q3 		$355K Buy
26,662
+3,300
+14% +$43.7K ﹤0.01% 1101
2017
Q2 		$334K Buy
23,362
+2,979
+15% +$57.3K ﹤0.01% 1083
2017
Q1 		$430K Sell
20,383
-25,017
-55% -$615K ﹤0.01% 1083
2016
Q4 		$1.28M Buy
+45,400
New +$1.27M 0.01% 893

Other funds holding CHRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Cornerstone Capital Management Holdings's CHRS Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Coherus Oncology (CHRS) stake by 34% in Q4 2017, buying an estimated $97.4K and bringing the position to 35,762 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

Cornerstone Capital Management Holdings first reported a position in CHRS in Q4 2016 and has held it in 5 quarters since. The position peaked at $1.28M in Q4 2016. 94 funds tracked by Wall St. Rank hold CHRS as of Q4 2017.

  • Cornerstone Capital Management Holdings held 35,762 shares of Coherus Oncology worth $314K as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 9,100 Coherus Oncology shares in Q4 2017, an estimated $97.4K.
  • Coherus Oncology made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #1072 holding.
  • Cornerstone Capital Management Holdings first reported a position in Coherus Oncology in Q4 2016 and has held it in 5 quarters since.
  • Cornerstone Capital Management Holdings's Coherus Oncology position peaked at $1.28M in Q4 2016.
  • 94 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.